Stem Cell Composition Using Migrating Neuroblasts for Spinal Cord Repair
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current pharmacological treatments for spinal cord injury, such as methylprednisolone, have unclear therapeutic effects and side effects, while stem cell-based treatments lack a established method for effective nerve regeneration.
Innovation Solution
A composition using stem cells treated with a specific compound, Formula 1, to differentiate into migrating neuroblasts, which are then administered to treat spinal cord injury.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If stem cells are transplanted to treat spinal cord injury, then nerve cell regeneration is promoted, but the therapeutic effect is insufficient without established differentiation control
Solution Approach 1:
The patent applies parameter changes by treating stem cells with a specific compound (Formula 1) that alters the differentiation parameters of stem cells, inducing them to become migrating neuroblasts. This chemical parameter change provides a controlled method to enhance nerve regeneration efficacy without requiring complex physical or biological control systems.
2Speed
If pharmacological treatments like methylprednisolone are used for spinal cord injury, then immediate treatment is possible, but therapeutic effects are unclear and side effects occur
Solution Approach 1:
The patent employs preliminary action by pre-treating stem cells with the compound of Formula 1 before transplantation. This preliminary differentiation treatment ensures that the transplanted cells are already optimized for nerve regeneration, providing reliable therapeutic effects while maintaining rapid treatment capability.
3Reliability
If stem cells are treated with compound Formula 1 and cultured for 96-144 hours, then differentiation into migrating neuroblasts is achieved, but treatment time is extended
Solution Approach 1:
The compound of Formula 1 induces rapid differentiation of stem cells into migrating neuroblasts within 96-144 hours. This parameter change in differentiation speed achieves high nerve regeneration efficacy without requiring excessively long culture periods, balancing treatment reliability with time efficiency.
Data Source
AI summary
The present invention relates to a composition for treating a spinal cord injury and provides a composition for treating a spinal cord injury comprising, as an active ingredient, stem cells treated with a particular compound and then cultured.